Bones Tell Black Death Story

Ancient skeletons test positive for plague-causing bacteria.

Written byRina Shaikh-Lesko
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CROSSRAIL LTDTwenty-five skeletons uncovered in London last year appear to have been part of a larger burial ground for plague victims. DNA sequenced from teeth pulled from the remains confirmed the presence of Yersinia pestis, the bacteria that causes both bubonic and pneumonic plague. The skeletons were found when tunnels were being dug for London’s new Crossrail train line. Before the discovery, it was unclear where the city’s plague victims had been buried.

“This discovery is a hugely important step forward in documenting and understanding Europe’s most devastating pandemic,” he added. “Until Crossrail’s discovery, archaeologists had been unable to confirm the story,” Jay Carver, Crossrail’s lead archaeologist, said in a statement.

The Black Death peaked in Europe between 1348 and 1350, wiping out about 60 percent of London’s population. According to genome analysis comparing the ancient sample and a recent outbreak in Madacascar, the ancient strain may not be more virulent than the current strain. In 2011, researchers from McMasters University suggested that the strain that had caused the Black Death had died out.

This latest finding could help researchers understand the evolution of plague bacteria and “is useful information that could warn and avert potential epidemics and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies